Plinest Polynucleotide Injections: Evidence, Limits and Questions

Plinest Polynucleotide Injections: Evidence, Limits and Questions

Plinest is a product name used in discussions of injectable polynucleotide treatment. A name alone does not establish which formulation, concentration or intended use is being offered. If this treatment is proposed, ask to see the exact sealed product, manufacturer, label, batch, expiry date and instructions for use. The clinician should explain how that specific product and proposed injection site relate to the available evidence.

What are polynucleotide injections?

Polynucleotides and polydeoxyribonucleotides are families of DNA-derived materials studied in wound healing and aesthetic skin treatment. Products, molecular characteristics and injection protocols vary. Describing a material as natural or DNA-derived does not show that the body will automatically accept it, that it is risk-free, or that one product has the same evidence as another.

The current aesthetic evidence is limited

A 2025 systematic review included nine low- or moderate-quality studies involving 219 patients. It reported promising changes in wrinkles, texture and elasticity but found variation in injection areas and techniques and called for rigorous, higher-quality research. A 2026 review of randomised trials included seven trials and 183 participants across skin rejuvenation, scar prevention and wound healing. Its authors also highlighted small samples, different protocols and different outcome measures. These reviews do not justify guaranteed rejuvenation, a universal treatment course or one fixed duration.

Do not transfer claims between products or indications

Evidence for a particular polynucleotide or polydeoxyribonucleotide product, dose, body site or clinical purpose cannot be applied automatically to Plinest or to every cosmetic concern. Claims about collagen, elastin, hydration, pigmentation, hair growth, scarring or tissue regeneration need evidence that matches the exact product, route, site and patient group. An improvement on a study scale is not a promise of a visibly younger appearance for an individual.

Risks, suitability and recovery

Needle injections can cause pain, bleeding, bruising, redness, swelling and tenderness. Infection, persistent lumps, delayed inflammation, allergy and an unsatisfactory or uneven result are possible. The small studies in current reviews cannot rule out uncommon or delayed harms. Suitability may be affected by active infection or inflammation, allergy history, pregnancy or breastfeeding, immune or bleeding problems, medicines and previous procedures. The exact contraindications, warnings and aftercare must come from the current product instructions and an individual clinical assessment.

Questions for the consultation

Ask whether the proposed use appears in the exact product instructions, what evidence supports the intended body site and outcome, how many sessions are proposed and why, and when benefit will be assessed. Check the injector’s professional registration, training, insurance and experience with complications. Discuss alternatives, realistic change, discomfort, recovery, total cost, follow-up and the route for urgent or out-of-hours advice. A consultation may conclude that no injection or a different clinical opinion is appropriate.

Scope of this article

Dr Sknn is an independent private aesthetics and cosmetics clinic. This page is limited to cosmetic concerns and treatment considerations. Suitability, risks, recovery and current availability are confirmed during an individual consultation. New, changing or unexplained symptoms should be assessed by an appropriate healthcare professional before cosmetic treatment.